{"id":2383,"date":"2018-10-14T12:45:38","date_gmt":"2018-10-14T11:45:38","guid":{"rendered":"https:\/\/ibb.uab.cat\/?p=2383"},"modified":"2019-06-19T09:59:30","modified_gmt":"2019-06-19T08:59:30","slug":"el-grupo-de-nanobiotecnologia-del-ibb-uab-gana-un-proyecto-retos","status":"publish","type":"post","link":"https:\/\/ibb.uab.cat\/index.php\/2018\/10\/14\/el-grupo-de-nanobiotecnologia-del-ibb-uab-gana-un-proyecto-retos\/","title":{"rendered":"El grupo de Nanobiotecnologia del IBB-UAB gana un proyecto RETOS"},"content":{"rendered":"<p><img loading=\"lazy\" class=\"wp-image-2387 alignleft\" style=\"border-style: solid;\" src=\"https:\/\/ibb.uab.cat\/wp-content\/uploads\/Tonivillaverde-cara.jpg\" alt=\"\" width=\"208\" height=\"277\" srcset=\"https:\/\/ibb.uab.cat\/wp-content\/uploads\/Tonivillaverde-cara.jpg 1200w, https:\/\/ibb.uab.cat\/wp-content\/uploads\/Tonivillaverde-cara-225x300.jpg 225w, https:\/\/ibb.uab.cat\/wp-content\/uploads\/Tonivillaverde-cara-768x1024.jpg 768w, https:\/\/ibb.uab.cat\/wp-content\/uploads\/Tonivillaverde-cara-195x260.jpg 195w\" sizes=\"(max-width: 208px) 100vw, 208px\" \/><\/p>\n<p>El grupo de Nanobiotecnolog\u00eda del IBB-UAB, liderado por el Dr. Antoni Villaverde, junto al Dr. Ram\u00f3n Mangues del Institut de Recerca de l&#8217;Hospital Sant Pau\u00a0y la empresa\u00a0NANOLIGENT ganan el proyecto de la convocatoria Retos-Colaboraci\u00f3n del a\u00f1o 2017, publicada en la Resoluci\u00f3n de 27 de octubre de 2017:<\/p>\n<p>T\u00cdTULO DEL PROYECTO: <em><strong>NANOTRAC. &#8220;Desarrollo de un nuevo medicamento selectivo con potente actividad antimetast\u00e1tica&#8221;<\/strong><\/em><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>\u00a0 \u00a0 \u00a0 \u00a0 \u00a0<img loading=\"lazy\" class=\"alignnone size-full wp-image-1846\" src=\"https:\/\/ibb.uab.cat\/wp-content\/uploads\/FEDER2.jpg\" alt=\"\" width=\"276\" height=\"69\" srcset=\"https:\/\/ibb.uab.cat\/wp-content\/uploads\/FEDER2.jpg 276w, https:\/\/ibb.uab.cat\/wp-content\/uploads\/FEDER2-272x69.jpg 272w\" sizes=\"(max-width: 276px) 100vw, 276px\" \/>\u00a0\u00a0<img loading=\"lazy\" class=\"alignnone size-full wp-image-2386\" src=\"https:\/\/ibb.uab.cat\/wp-content\/uploads\/logo_mciu.png\" alt=\"\" width=\"278\" height=\"70\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>El grupo de Nanobiotecnolog\u00eda del IBB-UAB, liderado por el Dr. Antoni Villaverde, junto al Dr. Ram\u00f3n Mangues del Institut de Recerca de l&#8217;Hospital Sant Pau\u00a0y la empresa\u00a0NANOLIGENT ganan el proyecto de la convocatoria Retos-Colaboraci\u00f3n del a\u00f1o 2017, publicada en la Resoluci\u00f3n de 27 de octubre de 2017: T\u00cdTULO DEL PROYECTO: NANOTRAC. &#8220;Desarrollo de un nuevo [&hellip;]<\/p>\n","protected":false},"author":65,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[4],"tags":[],"_links":{"self":[{"href":"https:\/\/ibb.uab.cat\/index.php\/wp-json\/wp\/v2\/posts\/2383"}],"collection":[{"href":"https:\/\/ibb.uab.cat\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ibb.uab.cat\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ibb.uab.cat\/index.php\/wp-json\/wp\/v2\/users\/65"}],"replies":[{"embeddable":true,"href":"https:\/\/ibb.uab.cat\/index.php\/wp-json\/wp\/v2\/comments?post=2383"}],"version-history":[{"count":3,"href":"https:\/\/ibb.uab.cat\/index.php\/wp-json\/wp\/v2\/posts\/2383\/revisions"}],"predecessor-version":[{"id":2405,"href":"https:\/\/ibb.uab.cat\/index.php\/wp-json\/wp\/v2\/posts\/2383\/revisions\/2405"}],"wp:attachment":[{"href":"https:\/\/ibb.uab.cat\/index.php\/wp-json\/wp\/v2\/media?parent=2383"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ibb.uab.cat\/index.php\/wp-json\/wp\/v2\/categories?post=2383"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ibb.uab.cat\/index.php\/wp-json\/wp\/v2\/tags?post=2383"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}